Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-19T05:22:47.505Z Has data issue: false hasContentIssue false
  • English
  • Français

East North Central Region Has the Highest Prevalence of Vancomycin-Resistant Enterococcus faecalis in the United States

Published online by Cambridge University Press:  02 January 2015

Sumanth Gandra ,
Nikolay Braykov  and
Ramanan Laxminarayan
Sumanth Gandra*
Affiliation:
Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts
Nikolay Braykov
Affiliation:
Center for Disease Dynamics, Economics, and Policy, Washington, DC
Ramanan Laxminarayan
Affiliation:
Center for Disease Dynamics, Economics, and Policy, Washington, DC Public Health Foundation of India, New Delhi, India Princeton Environmental Institute, Princeton University, Princeton, New Jersey
*
55 Lake Avenue, Worcester, MA 01545 ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 34 , Issue 4 , April 2013 , pp. 443 - 445
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2013

References

1.Hayakawa, K, Marchaim, D, Vidaillac, C. Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2011;32(9):52–55.Google Scholar
2.Dowzicky, MJ. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009. Clin Ther 2011;33:1964–1973.Google Scholar
3.Sahm, DF, Marsilio, MK, Piazza, G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database—USA. Clin Infect Dis 1999;29(2):259–263.Google Scholar
4.Hoffmann, MS, Eber, MR, Laxminarayan, R. Increasing resistance of Acinetobacter species to imipenem in United States hospitals, 1999–2006. Infect Control Hosp Epidemiol. 2010;31(2):196–197.Google Scholar
5.Klein, E, Smith, DL, Laxminarayan, R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999–2006. Emerg Infect Dis 2009;15(12):1925–1930.Google Scholar
6.Mera, RM, Miller, L, Amrine-Madsen, H, Sahm, DF. The impact of the pneumococcal conjugate vaccine on antimicrobial resistance in the United States since 1996: evidence for a significant rebound by 2007 in many classes of antibiotics. Microb Drug Resist 2009;15(4):261–268.Google Scholar
7.Sun, L, Klein, EY, Laxminarayan, R. Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clin Infect Dis 2012;55(3):1–8.CrossRefGoogle ScholarPubMed
8.Centers for Disease Control and Prevention (CDC). CDC Reminds Clinical Laboratories and Healthcare Infection Preventionists of Their Role in the Search and Containment of Vancomycin-Resistant Staphylococcus aureus (VRSA). Atlanta: CDC, 2012. http://www.cdc.gov/hai/settings/lab/vrsa_lab_search_containment.html. Accessed November 26, 2012.Google Scholar
9.Périchon, B, Courvalin, P. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009;53(11):4580–4587.Google Scholar
10.Zhu, W, Murray, PR, Huskins, WC, et al.Dissemination of an Enterococcus Inc18-like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010;54(10):4314–4320.CrossRefGoogle ScholarPubMed